Abstract:Background: Ventilator-associated pneumonia (VAP) is one of the most common healthcare-related infections in pediatric and neonatal intensive care units. In the present study, due to the importance of prevention, early identification, and treatment of VAP, nasal and endotracheal microorganisms were determined in intubated patients admitted to the pediatric intensive care unit. Objectives: The present study aims to determine the nasal and endotracheal (ETT) microorganisms in pediatric patients with intubated VAP admitted to the pediatric intensive care unit (PICU). Methods: This cross-sectional two-group case-control study was conducted on 90 intubated patients: 60 patients with VAP (30 nasal, 30 tracheal tubes) and 30 patients without VAP, hospitalized in the PICU department of Amirul Mominin Ali (AS) Hospital in Zabol, Iran, from March 2018 to December 2018. The criteria for diagnosing VAP was the clinical pulmonary infection score (CPIS). In both case and control groups, samples were collected from nasal tubes using nasal swabs and from tracheal tubes (ETT) as tracheal aspirates from intubated patients, and sent to the laboratory for culture. The collected samples were interpreted in the microbiology laboratory to identify microorganisms. Data collection was done using a demographic information questionnaire and the clinical pulmonary infection score CPIS. The data was entered into SPSS 20 statistical software and analyzed. Results: The results of the present study showed that gender and age of patients do not affect the incidence of VAP, but children with VAP have a significantly longer stay in the PICU. Microbiological examination showed that Klebsiella and Escherichia coli (13.3%) were the most frequent among the positive nasal samples, and Klebsiella and E. coli (36.7%) were the most frequent among the positive tracheal samples. The diversity of microbes observed in ETT samples was also higher. Conclusions: The present study showed that the duration of hospitalization in the pediatric intensive care unit, as well as the age of hospitalized patients, can increase the risk of VAP. Additionally, nasal sampling is effective in identifying and differentiating VAP patients. It is suggested to reduce the duration of hospitalization in these departments as much as possible and to pay more attention to older children to prevent the increase of VAP. The results indicate that nasal bacteria play a role in the more severe occurrence of ventilator-induced pneumonia. Therefore, it is recommended to use broad-spectrum antibiotics and implement preventive nursing measures. If possible, starting feeding earlier through a gastric tube is also suggested.

Early Predictors of Ventilator Associated Pneumonia in Preterm Neonates Admitted in a Special Newborn Care Unit

Microbial Investigations in Throat Swab and Tracheal Aspirate Specimens Are Beneficial to Predict the Corresponding Endotracheal Tube Biofilm Flora among Intubated Neonates with Ventilator-Associated Pneumonia

Risk factors and outcomes for ventilator-associated pneumonia in neonatal intensive care unit patients.

Microbiological Analysis of Endotracheal Aspirate and Endotracheal Tube Cultures in Mechanically Ventilated Patients.

Impact Clinically Related Factors on the Outcomes of Ventilator-Associated Pneumonia

Incidence, Risk Factors, Short-term Outcomes, and Microbiome of Ventilator-associated Pneumonia in Very-low-birth-weight Infants: Experience at a Single Level III Neonatal Intensive Care Unit

Molecular Quantification of Pseudomonas Aeruginosa from Respiratory Samples in Patients with Suspected Ventilator Associated Pneumonia

Exploring Ventilator-Associated Pneumonia: Microbial Clues and Biomarker Insights from a Retrospective Study

Risk factors and outcome of ventilator associated pneumonia in children aged 1 month to 12 years admitted in paediatric intensive care unit of a tertiary care hospital in Northern India

Pathogenic analysis of sputum from ventilator-associated pneumonia in a pediatric intensive care unit.

Variations and National Perspectives on Evaluation and Management of Ventilator-Associated Pneumonia in Neonatal Intensive Care Units: An In-Depth Survey Analysis

Analysis of risk factors for early-onset ventilator-associated pneumonia in a neurosurgical intensive care unit

Applying evidence-based prevention bundle strategies of ventilator-associated pneumonia in ventilated neonates

Incidence of Ventilator-Associated Pneumonia and its Bacterial Characterization – Intervention Based Prospective Study

Determination of Nasal and Endotracheal (ETT) Microorganisms in Pediatric Patients with Intubated VAP Admitted to the Pediatric Intensive Care Unit (PICU)

Analysis of the risk factors and pathogenic bacteria of ventilator-associated pneumonia

The spectrum of pneumonia among intubated neonates in the neonatal intensive care unit

Early Detection of Ventilator-associated Pneumonia From Exhaled Breath in Intensive Care Unit Patients

Risk factors of ventilator-associated pneumonia in infants and young children after open-heart surgery

Early Detection of Ventilator-Associated Pneumonia from Exhaled Breath in ICU Patients

Lung Microbiota and Ventilator-Associated Pneumonia in the Neonatal Period